Insulin resistance and cardiovascular disease risk factors in subjects with prehypertension
Hilla Knobler1, Fahim Abbasi, Cindy Lamendola
1Metabolic Unit, Kaplan Medical Center, Rehovot, Faculty of Medicine, Hebrew University-Hadassah Medical School, Jerusalem, Israel. Knobler@inter.net.il
Abstract:
Prehypertension is considered to be associated with increased cardiovascular disease (CVD), and some data suggest that insulin resistance is common in this group. The goal of this study was to quantify insulin action by determining the steady-state plasma glucose (SSPG) concentration during the insulin suppression test in apparently healthy individuals with prehypertension (n=126) and to elucidate the relationship between insulin action and CVD risk.We found a marked heterogeneity in insulin sensitivity in the prehypertension group, and when we divided the population into insulin-sensitive, insulin-resistant and intermediate groups, there were significant (p<0.01) increases in plasma glucose and triglyceride concentrations and decreases in high-density lipoprotein cholesterol concentrations with progressive degrees of insulin resistance. These data show that at least one-third of patients with prehypertension are insulin resistant, display the accompanying metabolic abnormalities, and merit enhanced surveillance and intensive efforts at therapeutic intervention to prevent CVD.
Related Concept Videos
Coronary Artery Disease I: Introduction
Hypertension II: Pathophysiology
Hypertension and Regulation of Blood Pressure
Hypertension III: Clinical Manifestations and Diagnostic Studies
Type II Diabetes I: Introduction
Type II Diabetes II: Pathophysiology
